Drug Trial Radar · NCT06238817
A Study to Evaluate the Efficacy, and Safety Study of Ruxolitinib Cream in Adults With Moderate Atopic Dermatitis
Last checked: Nov 20, 2026Latest source record: Oct 15, 2026 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
241
Actual
Start
Apr 26, 2024
Primary completion
May 21, 2025
Study completion Oct 17, 2025
Sponsor
- Lead sponsor
- Incyte CorporationIncyte (INCY)
- Sponsor type
- Industry
- First posted
- Feb 2, 2024
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Parallel
- Masking
- Quadruple (participant, care provider, investigator, outcomes assessor)
- Primary purpose
- Treatment
- FDA-regulated drug
- Yes
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
This study is being conducted to establish the efficacy of ruxolitinib cream in participants with moderate AD who had an inadequate response to, or are intolerant to, or contraindicated to topical corticosteroid (TCS)s and topical calcineurin inhibitor (TCI)s.
Conditions
- Atopic Dermatitis
Interventions
Ruxolitinib CreamDrug
Ruxolitinib cream applied topically to the affected area as a thin film twice daily.
Vehicle CreamDrug
Matching vehicle cream applied topically to the affected area as a thin film twice daily.
Primary outcomes
What the sponsor says the trial is designed to measure.
- Percentage of Participants Achieving a ≥75% Improvement in the Eczema Area and Severity Index Score (EASI75) at Week 8Time frame: Baseline; Week 8
- Percentage of Participants With Investigator's Global Assessment Treatment Success (IGA-TS) at Week 8Time frame: Baseline; Week 8
Locations
94 sites in 14 countries. Site status is shown where the registry gives one.
Lynn Institute of the Ozarks
Little Rock, Arkansas
First Oc Dermatology
Fountain Valley, California
Center For Dermatology Cosmetic and Laser Surgery
Fremont, California
Medderm Associates, Inc
San Diego, California
Encore Medical Research, Llc Hollywood
Hollywood, Florida
Entrust Clinical Research
Miami, Florida
Lane Dermatology and Dermatologic Surgery
Columbus, Georgia
Marietta Dermatology the Skin Cancer Center Marietta
Marietta, Georgia
Arlington Dermatology
Rolling Meadows, Illinois
Northshore University Healthsystem
Skokie, Illinois
Oakland Hills Dermatology Pc
Auburn Hills, Michigan
Revival Research Institute, Llc Troy
Troy, Michigan
Best Skin Research
Camp Hill, Pennsylvania
International Clinical Research Tennessee Llc
Murfreesboro, Tennessee
Center For Clinical Studies Webster
Houston, Texas
Texas Dermatology Research Center
Plano, Texas
Rainey and Finklea Dermatology
San Antonio, Texas
North Sound Dermatology
Mill Creek, Washington
Paratus Clinical Research, Woden
Phillip, Australia
Premier Specialists Pty Ltd
Kogarah, New South Wales, Australia
Australian Clinical Research Network
Maroubra, New South Wales, Australia
Veracity Clinical Research
Woolloongabba, Queensland, Australia
Clinical Trials Sa
Campbelltown, South Australia, Australia
Skin Health Institute Inc.
Carlton, Victoria, Australia
Ulb Hospital Erasme
Brussels, Belgium
Cliniques Universitaires Ucl Saint-Luc
Brussels, Belgium
Universitair Ziekenhuis Antwerpen (Uza)
Edegem, Belgium
Universitair Ziekenhuis Gent (Uz Gent)
Ghent, Belgium
Grand Hopital de Charleroi
Gilly, Belgium
Dermatologie Handelskaai
Kortrijk, Belgium
Mhat Dr. Tota Venkova Ad
Gabrovo, Bulgaria
Medical Center Medconsult Pleven Ood
Pleven, Bulgaria
Ambulatory For Specialized Medical Help - Skin and Venereal Diseases
Sofia, Bulgaria
Dcc 'Alexandrovska', Eood
Sofia, Bulgaria
Medical Center Hera Eood
Sofia, Bulgaria
Diagnostic Consultative Center Xxviii
Sofia, Bulgaria
Medical Center Assoc. Prof. Vasilev
Sofia, Bulgaria
Skincare Studio Dermatology Centre
St. John's, Canada
Dermatology Research Institute Inc.
Calgary, Alberta, Canada
Dr. Chih-Ho Hong Medical Inc.
Surrey, British Columbia, Canada
Showing 40 of 94 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.